{
    "clinical_study": {
        "@rank": "75413", 
        "arm_group": [
            {
                "arm_group_label": "Electrocautery", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Use of electrocautery in tourniquet and without tourniquet total knee replacement surgery."
            }, 
            {
                "arm_group_label": "Bipolar Sealer Aquamantys", 
                "arm_group_type": "Active Comparator", 
                "description": "Use of bipolar sealer Aquamantys in tourniquet and tourniquetless total knee replacement surgical procedures."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will compare the clinical outcomes for patients undergoing a total knee\n      replacement using a bipolar sealer, the Aquamantys\u00ae System, as compared to standard\n      electrocautery. Total blood loss during the hospital stay and knee mobility and discharge\n      factors will be analyzed."
        }, 
        "brief_title": "Bipolar Sealer Aquamantys Use in Total Knee Replacement", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Osteoarthritis", 
            "Arthritis", 
            "Surgery", 
            "Infection", 
            "Inflammation", 
            "Disability", 
            "Hemorrhage"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Hemorrhage", 
                "Inflammation", 
                "Osteoarthritis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is \u226518 years of age\n\n          -  Patient has failed conservative therapy of osteoarthritis of the knee and has been\n             listed to undergo primary TKA\n\n          -  Patient is willing and able to provide written informed consent.\n\n          -  Pre-assessment Haemoglobin \u2265 11.0g/dl\n\n          -  Patient is suitable to receive spinal anaesthesia with no peripheral nerve blocks\n\n          -  Patients willing to undergo blood transfusion\n\n        Exclusion Criteria:\n\n          -  Patients that are listed for unicondylar or revision TKA\n\n          -  Patients who are being converted from a previous high tibial osteotomy and a previous\n             unicondylar knee arthroplasty\n\n          -  Fixed motor deficit thus affecting functional assessment of the knee\n\n          -  Patients presenting with a non-osteoarthritis degenerative knee diagnosis\n\n          -  Patients presenting with known contralateral knee osteoarthritis requiring\n             simultaneous bilateral TKA\n\n          -  Patients presenting with a history of previous knee infection\n\n          -  Patients presenting with a pre-operative knee range of motion < 85\u00b0\n\n          -  Knee deformity greater than 20 degrees varus or valgus\n\n          -  Patients presenting with a history of bleeding disorders and/or are on chronic blood\n             anticoagulation therapy\n\n          -  Patients with significantly impaired renal function (defined by EGFR >30)\n\n          -  Patients with allergy or sensitivity to non-steroidal anti-inflammatory drugs,\n             ropivacaine, ketoprofen or adrenaline\n\n          -  Patients presenting with an internal cardiac defibrillator\n\n          -  Women who are pregnant\n\n          -  Evidence of active (systemic or local) infection at time of surgery\n\n          -  Patients who have habitual opioid use\n\n          -  Patients who have a psychiatric or mental illness which could impair the consent\n             process or ability to complete patient-report questionnaires\n\n          -  Morbid obesity [BMI > 40]\n\n          -  Patients who are unwilling to undergo blood transfusion, if necessary\n\n          -  Patients who are receiving any implant used in conjunction with a customised-cutting\n             block system\n\n          -  Any patient who cannot or will not provide written informed consent for participation\n             in the study\n\n          -  Those whose prospects for a recovery to independent mobility would be compromised by\n             known coexistent, medical problems"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "112", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01736644", 
            "org_study_id": "TD-07709"
        }, 
        "intervention": [
            {
                "arm_group_label": "Electrocautery", 
                "description": "Use of electrocautery in tourniquet and tourniquetless total knee replacement surgery", 
                "intervention_name": "Electrocautery", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Bipolar Sealer Aquamantys", 
                "description": "Aquamantys use in tourniquet and tourniquetless total knee replacement.", 
                "intervention_name": "Bipolar sealer Aquamantys", 
                "intervention_type": "Device", 
                "other_name": [
                    "Aquamantys", 
                    "AQM", 
                    "Bipolar sealer"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "blood loss", 
            "bipolar sealer", 
            "aquamantys", 
            "total knee replacement", 
            "primary total knee arthroplasty"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Epsom", 
                        "country": "United Kingdom", 
                        "state": "Surrey", 
                        "zip": "Kt18 7EG"
                    }, 
                    "name": "South West London Elective Orthopaedic Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle upon Tyne", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Freeman Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Control Trial to Compare the Aquamantys System With Standard Electrocautery in Reducing Blood Loss in Primary Total Knee Arthroplasty", 
        "overall_official": {
            "affiliation": "SWLEOC", 
            "last_name": "Richard E Field, Md, PhD, FRCS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome will be total blood loss throughout the hospital stay.", 
            "measure": "Blood Loss", 
            "safety_issue": "No", 
            "time_frame": "upto to 72 hrs after surgery"
        }, 
        "reference": [
            {
                "PMID": "20145794", 
                "citation": "Marulanda GA, Krebs VE, Bierbaum BE, Goldberg VM, Ries M, Ulrich SD, Seyler TM, Mont MA. Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. Am J Orthop (Belle Mead NJ). 2009 Dec;38(12):E179-83."
            }, 
            {
                "PMID": "16525984", 
                "citation": "Marulanda GA, Ragland PS, Seyler TM, Mont MA. Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. Surg Technol Int. 2005;14:281-6."
            }, 
            {
                "PMID": "19675727", 
                "citation": "Pfeiffer M, Br\u00e4utigam H, Draws D, Sigg A. A new bipolar blood sealing system embedded in perioperative strategies vs. a conventional regimen for total knee arthroplasty: results of a matched-pair study. Ger Med Sci. 2005 Dec 13;3:Doc10."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01736644"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Discharge criteria evaluated.", 
            "measure": "Rehabilitation", 
            "safety_issue": "No", 
            "time_frame": "6-weeks"
        }, 
        "source": "Medtronic Surgical Technologies", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Surgical Technologies", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}